News
Speed, Scale, and Success – The Rise of Bispecific Antibodies in Targeted Therapies | Fierce Biotech
Speed, Scale, and Success: Why Rapid Bispecific Antibody Development Matters The Need for Speed in Drug Development With bispecific antibody innovation accelerating, speed has become a critical ...
4d
News-Medical.Net on MSNScaling B-cell cloning workflows for antibody developmentMathieu Bennet: In B-cell cloning, single-cell isolation occurs at two crucial stages. First, during the initial screening ...
BigBreda on MSN4d
Bullet Head the Entertainer Joker 1/6 Scale Review and UnboxingWelcome! From Hot Toys to Soosoo, from Asmus to Inart, this is where you’ll find unbiased reviews and livestreams! Enjoy ...
A new dataset for predicting antigen-antibody interactions, published in the prestigious machine learning conference NeurIPS 2023, will help accelerate AI drug discovery KYOTO, Japan--(BUSINESS ...
Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug development - TechCrunch
Archon Bioscience s, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding.The company aims to supercharge ...
Researchers at UC San Diego simulated a 6.9 earthquake to see if this 10-story building would hold its integrity. The Rubin ...
Those tweaks may improve one property—how easily the antibody can be made at scale, for instance—but have a disastrous effect on the many other attributes required, such as selectivity ...
Disorders caused by antibodies against platelet factor 4 (PF4) gained major attention during the pandemic, when platelet-activating anti-PF4 antibodies were found to explain vaccine-induced immune ...
The work, published today as a Reviewed Preprint in eLife, uses a high-throughput sequencing-based assay to quantify antibody immunity against circulating H3N2 flu strains in both children and adults.
“We do not test different scale-up strategies for our projects, as our scale-up strategy is not influenced by the specific product being expressed. Whether the product is a standard IgG1 ...
STUTTGART, Germany I June 27, 2025 I La Merie Publishing announced the release of its newest technology market report about gene therapy technologies for in vivo expression of antibodies. The report ...
Autoimmune hepatitis (AIH) is a severe autoimmune disease characterized by immune-mediated hepatocyte destruction, leading to hepatic necroinflammation, cirrhosis, and potential fatality. N6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results